NCT06623396 2026-02-11
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
Memorial Sloan Kettering Cancer Center
University of Alberta
DiaMedica Therapeutics Inc
North York General Hospital
Thomas Jefferson University
Centers for Disease Control and Prevention